Skip to Content

Triamcinolone Acetonide Intravitreal Injection

Last Updated: April 27, 2020
Status: Current

Products Affected - Description
    • Triesence intravitreal suspension for injection, Novartis, 40 mg/mL, 1 mL vial, NDC 00065-0543-01
Reason for the Shortage
    • Novartis has Triesence on shortage due to manufacturing delays.
Available Products
    • There are no presentations available

Estimated Resupply Dates

    • Novartis has Triesence 40 mg/mL 1 mL vials on limited allocation.


Updated April 27, 2020 by Michelle Wheeler, PharmD, Drug Information Specialist. Created September 27, 2019 by Rachael Freeman, PharmD, BCPS. © 2020, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.